Can Inhibitor-Resistant Substitutions in the Mycobacterium tuberculosis β-Lactamase BlaC Lead to Clavulanate Resistance?: a Biochemical Rationale for the Use of β-Lactam–β-Lactamase Inhibitor Combinations

類似資料

• Combinatorial active-site variants confer sustained clavulanate resistance in BlaC β-lactamase from Mycobacterium tuberculosis
  著者:: Egesborg, Philippe, 等
  出版事項: (2015)
• Hydrolysis of Clavulanate by Mycobacterium tuberculosis β-Lactamase BlaC Harboring a Canonical SDN Motif
  著者:: Soroka, Daria, 等
  出版事項: (2015)
• 1642. A Novel β-lactamase Inhibitor (Durlobactam, DUR) and β-Lactams Enhance Susceptibility Against Multidrug-Resistant (MDR) Mycobacterium abscessus (Mab)
  著者:: Dousa, Khalid M, 等
  出版事項: (2020)
• Biochemical and Structural Characterization of Mycobacterium tuberculosis β-Lactamase (BlaC) with the Carbapenems Ertapenem and Doripenem
  著者:: Tremblay, Lee W., 等
  出版事項: (2010)
• Kinetic and Structural Characterization of the Interaction of 6-Methylidene Penem 2 with the β-Lactamase from Mycobacterium tuberculosis
  著者:: Hazra, Saugata, 等
  出版事項: (2015)